SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...
Left: primary/scatter window SPECT reconstructions, plus synthetic and CT-based attenuation maps. Right: SPECT reconstructed images corrected using CT-based attenuation maps, synthetic attenuation ...
MILabs, B.V. the Netherlands‐based innovator and manufacturer of pre‐clinical SPECT/PET/CT imaging devices announces the release of the Plus! Systems: the U‐SPECT + and U‐SPECT + /CT. Both systems ...
Image was selected as “Image of the Month” in the European Journal of Nuclear Medicine and Molecular Imaging, November 2023 SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc.